相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of Avoidable and Bias-Inflicting Methodological Pitfalls in Real-World Studies of Medication Safety and Effectiveness
Katsiaryna Bykov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Initiator Types and the Causal Question of the Prevalent New-User Design: A Simulation Study
Michael Webster-Clark et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
Initiator Types and the Causal Question of the Prevalent New-User Design: A Simulation Study
Michael Webster-Clark et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Kristian B. Filion et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Avoidable flaws in observational analyses: an application to statins and cancer
Barbra A. Dickerman et al.
NATURE MEDICINE (2019)
Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study
Viktor Wintzell et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study
Viktor Wintzell et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study
Hui-Min Diana Lin et al.
DRUGS-REAL WORLD OUTCOMES (2019)
Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study
Henrik Svanstrom et al.
DRUG SAFETY (2018)
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
Antonios Douros et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
Antonios Douros et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
Peter Ueda et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Blanaid M. Hicks et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The importance and implications of comparator selection in pharmacoepidemiologic research
Monica D'Arcy et al.
CURRENT EPIDEMIOLOGY REPORTS (2018)
Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
Samy Suissa et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening
Xabier Garcia-Albeniz et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Per-Protocol Analyses of Pragmatic Trials
Miguel A. Hernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approach
Joshua J. Gagne
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Mikhail Kosiborod et al.
CIRCULATION (2017)
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available
Miguel A. Hernan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis
Timothy Beukelman et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Beyond the intention-to-treat in comparative effectiveness research
Miguel A. Hernan et al.
CLINICAL TRIALS (2012)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Invited Commentary: Positivity in Practice
Daniel Westreich et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
A basic study design for expedited safety signal evaluation based on electronic healthcare data
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Observational Studies Analyzed Like Randomized Experiments An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease
Miguel A. Hernan et al.
EPIDEMIOLOGY (2008)
分享论文
